CVS Health reported better-than-expected Q1 earnings with adjusted EPS of $2.57, surpassing estimates of $2.20, and sales rising 6.2% to $100.43 billion. The company saw improved operating income driven by its Health Care Benefits segment and lowered its medical benefit ratio, reflecting cost efficiencies. Despite a decline in medical membership due to exiting the individual exchange business, prescription volume grew 3.6%. CVS also raised its 2026 adjusted earnings guidance to $7.30-$7.50 per share and plans to accelerate adoption of lower-cost biosimilars to reduce drug costs further.
CVS Health shares surged 7.65% following a strong Q1 2026 earnings report, beating EPS estimates with $2.57 adjusted EPS and 6.2% revenue growth to $100.4 billion. The key driver was Aetna's 52.6% jump in adjusted operating income and improved medica...
CVS Health has sold its Omnicare long-term care pharmacy network to GenieRx for $250 million, following approval from a bankruptcy court. The sale is part of CVS's strategy to concentrate on more profitable areas after Omnicare underperformed and fac...
CVS Health and WGU have partnered to offer an online pre-pharmacy Associate of Science degree aimed at reducing financial barriers for CVS employees pursuing pharmacy careers. The program provides flexible, affordable coursework with tuition assistan...
The U.S. Bankruptcy Court approved the sale of Omnicare, a CVS Health subsidiary providing pharmacy services to long-term care facilities, to GenieRx Holdings LLC, a partnership of Milrose Capital and Integro Healthcare Services. This sale marks a ne...
MinuteClinic, located in select CVS Pharmacy stores across 49 states and D.C., offers a clinically supervised weight-loss program available seven days a week, including evenings and weekends, through both in-person and virtual visits. The program has...
